1Andersen T,Gluud C.Liver morphology in morbid obesity:a literature study[J].Int J Obes,1984,8:97-106.
2Bellentani S,Saccocio G,Masutti F,et al.Prevalence of and risk factors for hepatic steatosis in northern Italy[J].Ann Intern Med,2000,132:112-117.
3Guenther Boden.Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver[J].Current Science Inc,2006,6:177-181.
4Fan JG,Saibara T,Chitturi S,et al.What are the risk factors andsettings for non-alcoholic fatty liver disease in Asia-Pacific?[J].J Gastroenterol Hepatol,2007,22:794-800.
5Fan JG.Impact of non-alcoholic fatty liver disease on accelerated metabolic complications[J].J Dig Dis,2008,9(2):63-67.
7Shibata M,Kihara Y,Taguchi M,et al.Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men[J].Diabetes Care,2007,30:2940-2944.
8Schindhelm RK,Diamant M,Dekker JM,et al.Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease[J].Diabetes Metab Res Rev,2006,22(6):437-443.
9Hanley AJ,Williams K,Festa A,et al.Liver markers and development of the metabolic syndrome:the insulin resistance atherosclerosis study[J].Diabetes,2005,54:3140-3147.
10Ali R,Cusi K.New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)[J].Annals of Medicine,2009,41:265-278.
